Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Planet 13 HoldingsFRA:Y7Q 20 Days Inventory is 137.11 as of Mar. 2026, which is 49% above its 10-year median of 91.75. GuruFocus rates FRA:Y7Q with a GF Score™ of 20/100 and a GF Value™ of €0.25 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 923 Drug Manufacturers companies, Planet 13 Holdings ranks better than 65.33% on this metric.
The historical rank and industry rank for Planet 13 Holdings's Days Inventory or its related term are showing as below:
FRA:Y7Q'
s Days Inventory Range Over the Past 10 Years
Min: 67.43 Med: 91.75 Max: 220.7
Current: 129.69
During the past 10 years, Planet 13 Holdings's highest Days Inventory was 220.70. The lowest was 67.43. And the median was 91.75.
FRA:Y7Q's Days Inventory is ranked better than 65.33% of 923
companies
in the Drug Manufacturers industry
Industry Median: 164.38
vs FRA:Y7Q: 129.69
Planet 13 Holdings's Days Inventory
increased
from Mar. 2025 (135.99) to Mar. 2026 (137.11).
It might indicate that Planet 13 Holdings's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Planet 13 Holdings's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.67.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Planet 13 Holdings's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.83.
Planet 13 Holdings (FRA:Y7Q) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Planet 13 Holdings's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Planet 13 Holdings's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Planet 13 Holdings Days Inventory Related Terms
Planet 13 Holdings Days Inventory Historical Data
* Premium members only.
The historical data trend for Planet 13 Holdings's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Planet 13 Holdings's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Planet 13 Holdings Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Planet 13 Holdings's Days Inventory distribution charts can be found below:
* The bar in red indicates where Planet 13 Holdings's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Planet 13 Holdings (FRA:Y7Q) has a Days Inventory of 137.11 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Planet 13 Holdings and its competitors. This is 49% above median its historical median of 91.75. Over the past decade, Planet 13 Holdings' Days Inventory has ranged from 67.43 to 220.70. According to the industry distribution chart, Planet 13 Holdings ranks #320 out of 923 companies in the Drug Manufacturers industry, placing it in the top 34.7%.
Is Planet 13 Holdings' Days Inventory too high?
Planet 13 Holdings' current Days Inventory of 137.11 is 49% above median its 10-year median of 91.75. Over the past 10 years, this metric has ranged from a low of 67.43 to a high of 220.70. The Drug Manufacturers industry median Days Inventory is 164.38. Planet 13 Holdings' value of 137.11 is 16.6% below this industry median. Based on the distribution chart, Planet 13 Holdings ranks #320 out of 923 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Planet 13 Holdings has a GF Score™ of 20/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Planet 13 Holdings' Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Planet 13 Holdings ranks #320 out of 923 companies for Days Inventory. This puts Planet 13 Holdings in the upper half of its industry. The industry median Days Inventory is 164.38. Planet 13 Holdings' value of 137.11 is 16.6% below this benchmark. Historically, Planet 13 Holdings' own Days Inventory has ranged from 67.43 to 220.70 over the past decade. While the company's 10-year median is 91.75 vs. the industry median of 164.38, Planet 13 Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.38, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Planet 13 Holdings's current Days Inventory of 137.11 is 16.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Planet 13 Holdings and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Planet 13 Holdings's current Days Inventory is 137.11, which is 49% above median its own 10-year median of 91.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Planet 13 Holdings stock overvalued right now?
Based on GuruFocus' analysis, Planet 13 Holdings (FRA:Y7Q) is currently considered Possible Value Trap. The stock's GF Value™ is €0.25, compared to a current price of €0.11 — trading 54.4% below its estimated fair value. The current Days Inventory is 137.11, which is 49% above median its 10-year median of 91.75 and 16.6% below the Drug Manufacturers industry median of 164.38. Planet 13 Holdings' overall GF Score™ is 20/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Planet 13 Holdings (FRA:Y7Q), the current Days Inventory is 137.11 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Planet 13 Holdings (FRA:Y7Q) Overvalued in 2026?
Based on GuruFocus' analysis, Planet 13 Holdings stock appears to be undervalued.
The current stock price of €0.11 is trading 54.4% below its estimated GF Value™ of €0.25.
GuruFocus considers Planet 13 Holdings to be Possible Value Trap.
Key valuation signals for FRA:Y7Q:
Days Inventory: 137.11 (49% above median its 10-year median of 91.75)
GF Value™: €0.25 vs. price of €0.11 (54.4% below fair value)
Industry Position: 16.6% below the Drug Manufacturers median (#320 of 923)
No single metric tells the full story. See the FRA:Y7Q stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Planet 13 Holdings Inc a vertically integrated cultivator and provider of cannabis and cannabis-infused products in the States of Nevada and California, with retail cannabis operations in Illinois. The company owns and manufactures cannabis products under the following brands: HaHa (gummies and beverages), Dreamland (chocolates), TRENDI (vapes and concentrates), Medizin (flower, vapes, concentrates), Leaf and Vine (vapes).
20GF Score
Get the complete analysis for FRA:Y7Q
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:Y7Q has been successfully added to your 
